Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.67 USD | -3.02% | +11.06% | -11.92% |
18/04 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
16/04 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.92% | 2.13B | |
+9.39% | 106B | |
+1.15% | 104B | |
+6.72% | 23.25B | |
-13.50% | 22.5B | |
-6.64% | 18.7B | |
-37.08% | 17.95B | |
-11.04% | 16.99B | |
+7.62% | 14.26B | |
+40.05% | 12.76B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals, Inc. acquired substantially all the assets of Vium, Inc. for $2.6 million.